These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21521133)

  • 1. Safe use of long-acting β-agonists: what have we learnt?
    Sears MR
    Expert Opin Drug Saf; 2011 Sep; 10(5):767-78. PubMed ID: 21521133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of asthma mortality with inhaled long acting beta-agonists.
    Wijesinghe M; Perrin K; Harwood M; Weatherall M; Beasley R
    Postgrad Med J; 2008 Sep; 84(995):467-72. PubMed ID: 18940948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting beta-agonists: a review of formoterol safety data from asthma clinical trials.
    Sears MR; Ottosson A; Radner F; Suissa S
    Eur Respir J; 2009 Jan; 33(1):21-32. PubMed ID: 18768573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review.
    Rodrigo GJ; Moral VP; Marcos LG; Castro-Rodriguez JA
    Pulm Pharmacol Ther; 2009 Feb; 22(1):9-19. PubMed ID: 19026757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of long-acting beta2-agonists in the treatment of asthma.
    Cazzola M; Matera MG
    Ther Adv Respir Dis; 2007 Oct; 1(1):35-46. PubMed ID: 19124346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.
    Tamm M; Richards DH; Beghé B; Fabbri L
    Respir Med; 2012 Dec; 106 Suppl 1():S9-19. PubMed ID: 23273165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of long-acting beta-agonists: are new data really required?
    Sears MR
    Chest; 2009 Aug; 136(2):604-607. PubMed ID: 19505986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.
    Gibson PG; Powell H; Ducharme FM
    J Allergy Clin Immunol; 2007 Feb; 119(2):344-50. PubMed ID: 17291852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy in asthma--fixed or variable dosing in different patients?
    Lötvall J
    Curr Med Res Opin; 2004 Nov; 20(11):1711-27. PubMed ID: 15537472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of formoterol in adults and children with asthma: a meta-analysis.
    Kemp J; Armstrong L; Wan Y; Alagappan VK; Ohlssen D; Pascoe S
    Ann Allergy Asthma Immunol; 2011 Jul; 107(1):71-8. PubMed ID: 21704888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma: fatal exacerbations with long-acting beta2 agonist therapy without concomitant steroid therapy.
    Prescrire Int; 2007 Apr; 16(88):69-70. PubMed ID: 17458051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination inhalers containing inhaled corticosteroids and long-acting beta2-agonists: improved clinical efficacy and dosing options in patients with asthma.
    Ankerst J
    J Asthma; 2005 Nov; 42(9):715-24. PubMed ID: 16316864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.
    Cave AC; Hurst MM
    Pharmacol Ther; 2011 May; 130(2):114-43. PubMed ID: 21276815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting beta-agonists role in asthma management.
    Donohue JF; Fromer L
    J Fam Pract; 2006 Apr; Suppl():1-6. PubMed ID: 16715643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting β-agonists in asthma management: what is the current status?
    Mysore S; Ruffin RE
    Drugs; 2011 Nov; 71(16):2091-7. PubMed ID: 22035511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE; Noonan MJ
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma.
    Buhl R; Vogelmeier C
    Curr Med Res Opin; 2007 Aug; 23(8):1867-78. PubMed ID: 17605896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluticasone/formoterol: a new single-aerosol combination therapy for patients with asthma.
    Dissanayake S; Grothe B; Kaiser K
    Respir Med; 2012 Dec; 106 Suppl 1():S20-8. PubMed ID: 23273163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is it safe to use long-acting beta-agonists in asthma and chronic obstructive pulmonary disease? Implications of recent trials and meta-analyses.
    Sears MR
    Pol Arch Med Wewn; 2008 Dec; 118(12):761-6. PubMed ID: 19202956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.